OpenAlex
PricingAboutJobs
Log inGet started
Work

The role of nonrandomized trials in the evaluation of oncology drugs

HTML

Year: 2015
Type: article
Source: Clinical Pharmacology & Therapeutics
DOI: 10.1002/cpt.86
Authors: R Simon, GM Blumenthal, ML Rothenberg, J Sommer, SA Roberts, DK Armstrong, LM LaVange, R Pazdur
Institutions: National Cancer Institute, United States Food and Drug Administration, Pfizer (United States), Chordoma Foundation, Friends of Cancer Research, Johns Hopkins University
Language: English

Topic: Statistical Methods in Clinical Trials
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Keywords: oncology drug approval, drug safety and efficacy, unmet medical needs, risk-benefit assessment, historical control groups, tumor response rate, drug development
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2133660198
FWCI: 4.329
Cites: 17
Cited by: 71
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security